Immunization onto bare skin with synthetic peptides: Immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells

Immunology

Volumn 105, Issue 2, 2002, Pages 204-212

  Beignon, Anne Sophie ^a   Briand, Jean Paul ^a   Muller, Sylviane ^a   Partidos, Charalambos D ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CD4 ANTIGEN; CHOLERA TOXIN; GAMMA INTERFERON; HEMAGGLUTININ; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 4; OLIGODEOXYNUCLEOTIDE; SYNTHETIC PEPTIDE; THYMIDINE; TRITIUM; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOMODULATION; INFLUENZA VIRUS; LYMPH NODE; LYMPHOCYTE; MOLECULAR SIZE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN; SPLEEN; STIMULATION; SUPERNATANT; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CHOLERA TOXIN; DNA; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNIZATION; IMMUNOGLOBULIN G; INFLUENZA VACCINES; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; SPLEEN;

EID: 0036172532     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0019-2805.2001.01357.x     Document Type: Article

References (48)

1. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: Model-based regional estimates
2. Unsafe injections in the developing world and transmission of blood-borne pathogens: A review
3. Skin immunisation made possible by cholera toxin
4. The bare skin and the nose as non-invasive routes for administering peptide vaccines
5. The skin as a barrier: Structure and function
6. The skin immune system. Its cellular constituents and their interactions
7. Immunity at the surface: Homeostatic mechanisms of the skin immume system
8. Transcutaneous immunisation with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
9. Transcutaneous immunisation with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants
10. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to co-administered protein and peptide antigens and protects mice against lethal toxin challenge
11. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
12. Contribution of CpG motifs to the immunogenicity of DNA vaccines
13. The role of CpG motifs in innate immunity
14. A Toll-like receptor recognizes bacterial DNA
15. Phylogenetic perspectives in innate immunity
16. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
17. Therapeutic applications of CpG-containing oligodeoxynucleotides
18. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice
19. Anti-peptide antibody responses following intranasal immunization: Effectiveness of mucosal adjuvants
20. The 500 Dalton rule for the skin penetration of chemical compounds and drugs
21. + T cell subsets during virus infection: Protective capacity depends on effector cytokine secretion and on migratory capability
22. Cholera toxin suppresses interleukin IL-12 production and IL-12 receptor β1 and β2 chain expression
23. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
24. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs
25. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG olligodeoxynucleotides as a novel antigen-specific immunomodulator
26. Laboratory protocols for the identification of Th cell epitopes on self-antigens in mice with systemic autoimmune diseases
27. Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response
28. Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B
29. Characteristics of oligonucleotide uptake in human keratinocyte cultures
30. Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes
31. Adjuvantation of epidermal powder immunization
32. Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis
33. Immunisation via hair follicles by topical application of naked DNA to normal skin
34. Vaccination onto bare skin
35. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin
36. On the role of polysialoglycosphingolipids as tetanus toxin receptors. A study with lipid monolayers
37. Non-invasive administration of drugs through the skin: Challenges in delivery system design
38. Advances in vaccine delivery: Transcutaneous immunisation
39. Transcutaneous immunization: A human vaccine delivery strategy using a patch
40. + T-cell subsets in vivo
41. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
42. + T-cells
43. CpG DNA as mucosal adjuvant
44. Synergistic antiviral and antiproliferafive activities of Escherichia coli-derived human alpha, beta and gamma interferons
45. Tumor necrosis factors α and β inhibit virus replication and synergize with interferons
46. Functional analysis of T lymphocyte subsets in antiviral host defence
47. + cytotoxic T cell responses during chronic viral infection